Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure (INNOVATE)
Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE
Sponsor: BrioHealth Solutions, Inc.
Listed as NCT06310031, this NA trial focuses on Cardiovascular Diseases and Heart Diseases and remains actively recruiting participants. Sponsored by BrioHealth Solutions, Inc., it has been updated 10 times since 2024, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Mar 2026 — Present [monthly]
Recruiting NA
-
Jan 2026 — Mar 2026 [monthly]
Recruiting NA
-
Nov 2025 — Jan 2026 [monthly]
Recruiting NA
-
Oct 2025 — Nov 2025 [monthly]
Recruiting NA
-
Sep 2025 — Oct 2025 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Aug 2025 — Sep 2025 [monthly]
Recruiting NA
-
Feb 2025 — Aug 2025 [monthly]
Recruiting NA
-
Nov 2024 — Feb 2025 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
-
Sep 2024 — Nov 2024 [monthly]
Withheld
-
Apr 2024 — Sep 2024 [monthly]
Withheld
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- BrioHealth Solutions, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .